Skip to main content

stock

PACB · PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

What PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reports to the SEC, read from its filings.

Open in the app

Price

The live PACB price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on PACB.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Laboratory Analytical Instruments (SIC 3826)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
310,830,759 as of 2026-07-31 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
36.4%
Operating
-83.5%
Net
-82.5%

Returns

ROE
—
ROA
-17.5%

Health

Current ratio
4.9x
Debt/equity
—

Deep value

NCAV
-$446.42M
NCAV per share
-$1.44
Price/NCAV
Locked
NNWC
-$670.19M
NNWC per share
-$2.16
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$39.01M$12.64M-$44.61M-$44.74M
10-Q filed 2026-08-06
2026-03-31$37.18M$12.84M-$8.36M-$8.28M
10-Q filed 2026-05-08
2025-12-31$44.65M$16.57M-$41.20M-$40.40M
DEF 14A filed 2026-04-23
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30$38.44M$15.90M-$38.88M-$38.00M
10-Q filed 2025-11-06
2025-06-30$39.77M$14.68M-$44.85M-$41.93M
10-Q filed 2026-08-06
2025-03-31$37.15M-$1.37M-$428.93M-$426.07M
10-Q filed 2026-05-08
2024-12-31$39.22M$10.06M-$153.03M$2.32M
DEF 14A filed 2026-04-23
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30$39.97M$10.00M-$64.08M-$60.73M
10-Q filed 2025-11-06
Assets
$751.85M
Equity
-$33.21M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$160.00M-$553.86M-$546.40M-$113.92M
2024-12-31$154.01M-$474.31M-$309.90M-$212.25M
2023-12-31$200.52M-$334.47M-$306.70M-$268.02M
2022-12-31$128.30M-$307.20M-$314.20M-$279.96M
2021-12-31$130.51M-$210.44M-$181.20M-$117.11M
2020-12-31$78.89M-$104.39M$29.40M$18.46M
2019-12-31$90.89M-$100.55M-$84.13M-$81.15M
2018-12-31$78.63M-$100.99M-$102.56M-$68.28M
2017-12-31$93.47M-$89.78M-$92.19M-$77.95M
2016-12-31$90.71M-$71.24M-$74.38M-$76.14M

Company filings

since Wed Feb 25

events

  • Results, Exit or restructuring costs, Executive or director change, Regulation FD disclosure

    ResultsExit or restructuring costsExecutive or director changeRegulation FD disclosure
    Aug 58-K
  • Executive or director change

    Executive or director change
    Jul 98-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    Jun 48-K
  • Results

    Results
    May 78-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Mar 68-K
  • Executive or director change, Regulation FD disclosure

    Executive or director changeRegulation FD disclosure
    Mar 58-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

News

Stories that named PACB, and the market events around them.

Sign in to see this

Board

The PACB board could not be loaded.

Retry the PACB board

nakagai

Signals on PACB come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the PACB board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB): SEC filings, financials and insider trades · Nakagai